Literature DB >> 19268662

CD148/DEP-1 association with areas of cytoskeletal organisation in macrophages.

Richa K Dave1, David A Hume, Caryn Elsegood, Stuart Kellie.   

Abstract

In macrophages, tyrosine phosphorylation regulates many signalling pathways leading to growth, differentiation, activation, phagocytosis and adhesion. Protein tyrosine phosphatases (PTPs) represent a biochemical counterbalance to the activity of protein tyrosine kinases, thus regulating the dynamic phosphorylation state of a cell. CD148 is a receptor PTP that is highly expressed in macrophages and is further regulated by pro-inflammatory stimuli. CD148 is normally localised to the plasma membrane of macrophages. Following stimulation with CSF-1 or LPS, there was a re-distribution and concentration of CD148 in areas of membrane ruffling. Treatment of macrophages with anti-CD148 monoclonal antibody inhibited CSF-1-induced macrophage spreading, cytoskeletal re-arrangements and chemotaxis, without affecting cell survival. There were no detectable effects on the CSF-1 receptor-akt signalling pathway. These results are consistent with the hypothesis that CD148 is a regulator of macrophage activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19268662     DOI: 10.1016/j.yexcr.2009.02.023

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase.

Authors:  Keiko Takahashi; Raymond L Mernaugh; David B Friedman; Rebecca Weller; Nobuo Tsuboi; Hironobu Yamashita; Vito Quaranta; Takamune Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

2.  Agonistic anti-CD148 monoclonal antibody attenuates diabetic nephropathy in mice.

Authors:  Keiko Takahashi; Rachel H Kim; Lejla Pasic; Lilly He; Shinya Nagasaka; Daisuke Katagiri; Tracy May; Akira Shimizu; Raymond C Harris; Raymond L Mernaugh; Takamune Takahashi
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-27

Review 3.  Regulation of tyrosine phosphorylation in macrophage phagocytosis and chemotaxis.

Authors:  Haein Park; Dan Ishihara; Dianne Cox
Journal:  Arch Biochem Biophys       Date:  2011-02-26       Impact factor: 4.013

4.  Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors.

Authors:  Chanel E Smart; Marjan E Askarian Amiri; Ania Wronski; Marcel E Dinger; Joanna Crawford; Dmitry A Ovchinnikov; Ana Cristina Vargas; Lynne Reid; Peter T Simpson; Sarah Song; Christiane Wiesner; Juliet D French; Richa K Dave; Leonard da Silva; Amy Purdon; Megan Andrew; John S Mattick; Sunil R Lakhani; Melissa A Brown; Stuart Kellie
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

Review 5.  Targeting Receptor-Type Protein Tyrosine Phosphatases with Biotherapeutics: Is Outside-in Better than Inside-Out?

Authors:  Yotis A Senis; Alastair J Barr
Journal:  Molecules       Date:  2018-03-02       Impact factor: 4.411

6.  Regulated expression of PTPRJ/CD148 and an antisense long noncoding RNA in macrophages by proinflammatory stimuli.

Authors:  Richa K Dave; Marcel E Dinger; Megan Andrew; Marjan Askarian-Amiri; David A Hume; Stuart Kellie
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

7.  Differential expression of CD148 on leukocyte subsets in inflammatory arthritis.

Authors:  Richa K Dave; Amy J Naylor; Stephen P Young; Rachel Bayley; Debbie L Hardie; Oliver Haworth; David A Rider; Andrew D Cook; Christopher D Buckley; Stuart Kellie
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.